CSIMarket
 


Dendreon Corp  (DNDN)
Other Ticker:  
 
 

DNDN's Net Cash Flow Growth by Quarter and Year

Dendreon's Net Cash Flow results by quarter and year




DNDN Net Cash Flow (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
IV Quarter December - 4.84 -38.29 0.00
III Quarter September -12.98 -4.32 -20.80 0.00
II Quarter June -23.18 -38.57 -90.17 0.00
I Quarter March -2.43 -57.83 -89.44 0.00
FY   -38.59 -95.88 -238.70 0.00



DNDN Net Cash Flow third quarter 2014 Y/Y Growth Comment
Dendreon Corp in the third quarter 2014 recorded net cash outflow of $ -12.98 millions.

According to the results reported in the third quarter 2014, Dendreon Corp achieved the best Net Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Dendreon Corp' s Net Cash Flow no change of % ranks overall at the positon no. in the third quarter 2014.




DNDN Net Cash Flow ( Y/Y Growth %) 2014
2013 2012 2011
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Dendreon's third quarter 2014 Net Cash Flow $ -12.98 millions DNDN's Income Statement
Dendreon's third quarter 2013 Net Cash Flow $ -4.32 millions Quarterly DNDN's Income Statement
New: More DNDN's historic Net Cash Flow Growth >>


DNDN Net Cash Flow (Quarter on Quarter Growth %)

2014
2013 2012 2011
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Dendreon's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DNDN's III. Quarter Q/Q Net Cash Flow Comment
Despite the fact, that Dendreon Corp in the III. Quarter 2014 showed net cash outflow of $ -12.98 millions, some analyst point out, that this point to improvement in contrast to the -23.18 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Dendreon Corp achieved highest sequential Net Cash Flow growth. While Dendreon's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DNDN's III. Quarter Q/Q Net Cash Flow Comment
Despite the fact, that Dendreon Corp in the III. Quarter 2014 showed net cash outflow of $ -12.98 millions, it should be point out, that current results point to recovery compare to the -23.18 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Dendreon Corp achieved highest sequential Net Cash Flow growth. While Dendreon's Net Cash Flow growth quarter on quarter, overall rank is .


Dendreon's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2014)
12 Months Ending
(Jun 30 2014)
12 Months Ending
(Mar 31 2014)
12 Months Ending
(Dec 31 2013)
12 Months Ending
(Sep 30 2013)
Cumulative Net Cash Flow 12 Months Ending $ -33.75 $ -25.09 $ -40.48 $ -95.88 $ -139.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Dendreon Corp achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment


Dendreon Corp achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
DNDN's Net Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for DNDN's Competitors
Net Cash Flow Growth for Dendreon's Suppliers
Net Cash Flow Growth for DNDN's Customers

You may also want to know
DNDN's Annual Growth Rates DNDN's Profitability Ratios DNDN's Asset Turnover Ratio DNDN's Dividend Growth
DNDN's Roe DNDN's Valuation Ratios DNDN's Financial Strength Ratios DNDN's Dividend Payout Ratio
DNDN's Roa DNDN's Inventory Turnover Ratio DNDN's Growth Rates DNDN's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2014 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2014
Mimedx Group Inc 328.64%$ 328.642 millions
Mallinckrodt Plc299.47%$ 299.474 millions
Allergan plc256.35%$ 256.352 millions
Globus Medical Inc 243.47%$ 243.469 millions
Sanomedics, Inc.234.73%$ 234.730 millions
Regenerx Biopharmaceuticals inc 231.75%$ 231.750 millions
Orasure Technologies Inc220.35%$ 220.352 millions
Aspira Women s Health Inc 182.87%$ 182.872 millions
Pro dex Inc 182.55%$ 182.550 millions
Dexcom Inc 163.46%$ 163.462 millions
Quest Diagnostics Inc160.57%$ 160.573 millions
Psychemedics Corp131.75%$ 131.747 millions
Mannkind Corporation101.08%$ 101.077 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com